http://www.mail.com/companies/25204-pfizer-inc.html Mail.com - the best personalized free web-based Email en en http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png http://www.mail.com/companies/25204-pfizer-inc.html http://www.mail.com/scitech/health/2067040-bashful-men-buy-blue-pill-online.html TRENTON, N.J. (AP) — Men who are bashful about needing help in the bedroom no longer have to go to the drugstore to buy that little blue pill. In a first for the drug industry, Pfizer Inc. told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra to patients on its website. Men still will need a prescript... Mon, 06 May 2013 21:09:01 GMT http://www.mail.com/scitech/health/2067040-bashful-men-buy-blue-pill-online.html 2013-05-06T21:09:01Z http://www.mail.com/business/economy/2057866-sanofi-earnings-slashed-quarter.html PARIS (AP) — French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings. Sanofi's net profit was €1 billion ($1.3 billion) in the January-March quarter, down 45 percent from €1.8 billion a year earlier. Revenue from Plavix, which had... Thu, 02 May 2013 06:55:07 GMT http://www.mail.com/business/economy/2057866-sanofi-earnings-slashed-quarter.html 2013-05-02T06:55:07Z http://www.mail.com/business/economy/2055676-generic-competition-cuts-mercks-q1-sales-profit.html Merck & Co. on Wednesday posted disappointing first-quarter results and cut its earnings forecast for the year. But the world's third-largest drugmaker predicted that things would soon improve. Merck was slammed by two factors plaguing most of its rivals: growing competition from generic drugs and unfavorable exchange rates. Major drugmakers in recent yea... Wed, 01 May 2013 20:56:47 GMT http://www.mail.com/business/economy/2055676-generic-competition-cuts-mercks-q1-sales-profit.html 2013-05-01T20:56:47Z http://www.mail.com/business/economy/2053902-stocks-drift-higher-pfizer-weighs-dow.html NEW YORK (AP) — The stock market is lower at midday on more evidence of a slowing U.S. economy. The Dow Jones industrial average is down 57 points to 14,781 as of 11:51 a.m. Eastern time. The Standard & Poor's 500 index is off six points at 1,591. The Nasdaq has fallen 13 points to 3,315. U.S. factory activity last month dropped to its slowest pace this y... Wed, 01 May 2013 16:08:38 GMT http://www.mail.com/business/economy/2053902-stocks-drift-higher-pfizer-weighs-dow.html 2013-05-01T16:08:38Z http://www.mail.com/business/economy/2053288-pfizer-1q-profit-up-drugmaker-cuts-outlook.html Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's expectations, and the company lowered its profit and sales forecasts for the year, blaming sudden worsening of currency exchange rates. Pfizer is struggl... Tue, 30 Apr 2013 21:25:59 GMT http://www.mail.com/business/economy/2053288-pfizer-1q-profit-up-drugmaker-cuts-outlook.html 2013-04-30T21:25:59Z http://www.mail.com/business/economy/2053056-markets-steady-despite-growing-ecb-rate-cut-talk.html MOSCOW (AP) — European markets steadied Tuesday following a strong performance the previous session despite growing expectations of an interest rate reduction from the European Central Bank later this week. The expectation that the ECB will cut its main interest rate from the already all-time low of 0.75 percent has grown after figures Tuesday showed euro... Tue, 30 Apr 2013 16:39:12 GMT http://www.mail.com/business/economy/2053056-markets-steady-despite-growing-ecb-rate-cut-talk.html 2013-04-30T16:39:12Z http://www.mail.com/business/economy/2053532-stocks-edge-lower-pfizer-weighs-dow.html NEW YORK (AP) — Weak earnings from Pfizer and other companies dragged down major market indexes Monday, pulling the Standard & Poor's 500 back from a record high. Pfizer's stock dropped 3 percent after the drug maker's results fell short of what analysts had expected, a result of currency movements and falling sales. The world's second-largest drug maker ... Tue, 30 Apr 2013 14:29:46 GMT http://www.mail.com/business/economy/2053532-stocks-edge-lower-pfizer-weighs-dow.html 2013-04-30T14:29:46Z http://www.mail.com/scitech/health/1991800-indias-rejection-drug-patent-reverberate.html The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers. The ruling, which was handed down on Monday, signals the latest shift in the world of drug development in emerging markets such as India and Brazil, where drugmakers have been lookin... Tue, 02 Apr 2013 01:06:08 GMT http://www.mail.com/scitech/health/1991800-indias-rejection-drug-patent-reverberate.html 2013-04-02T01:06:08Z http://www.mail.com/scitech/health/1976398-court-drug-companies-pay-to-delay-generics.html WASHINGTON (AP) — Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines that can top 90 percent. The Obama administration, backed by ... Mon, 25 Mar 2013 03:42:57 GMT http://www.mail.com/scitech/health/1976398-court-drug-companies-pay-to-delay-generics.html 2013-03-25T03:42:57Z http://www.mail.com/business/finance/1951666-us-business-bemoans-india-trade-protectionism.html WASHINGTON (AP) — American businesses complained to lawmakers Wednesday about Indian trade protectionism, contending that tariff and regulatory barriers are shutting out foreign firms despite the nation's market-opening reforms. Advocates for the pharmaceutical, information technology and agricultural industries detailed their grievances to a House subcom... Wed, 13 Mar 2013 18:35:56 GMT http://www.mail.com/business/finance/1951666-us-business-bemoans-india-trade-protectionism.html 2013-03-13T18:35:56Z http://www.mail.com/business/economy/1948036-drugmakers-interpol-ramp-up-fight-fakes.html More than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs, the international police agency said Tuesday. Interpol's newly created Pharmaceutical Crime Program aims to help health agencies, police and customs bureaus in countries around th... Tue, 12 Mar 2013 11:29:37 GMT http://www.mail.com/business/economy/1948036-drugmakers-interpol-ramp-up-fight-fakes.html 2013-03-12T11:29:37Z http://www.mail.com/business/economy/1891074-nestle-1155-billion-profit-2012.html VEVEY, Switzerland (AP) — Nestle SA, the world's biggest food and drinks maker, predicted another challenging year ahead but overcame tough global economic conditions to post a full-year net profit Thursday of 10.6 billion Swiss francs ($11.55 billion) for 2012. With 330,000 employees worldwide and 461 factories in 83 countries, Nestle is a major buyer of... Thu, 14 Feb 2013 17:26:24 GMT http://www.mail.com/business/economy/1891074-nestle-1155-billion-profit-2012.html 2013-02-14T17:26:24Z http://www.mail.com/scitech/health/1861964-news-summary-pfizer-animal-health-unit-ipo-soars.html GOOD START: Drugmaker Pfizer's initial public stock offering of its animal health business, Zoetis, raised $2.2 billion, the largest IPO by a U.S. company since Facebook Inc. raised $16 billion last May. Shares jumped 19 percent from their initial $26 price, closing at $31.01. PFIZER STAKE: For now, Pfizer Inc. retains ownership of at least 80 percent in ... Fri, 01 Feb 2013 21:30:00 GMT http://www.mail.com/scitech/health/1861964-news-summary-pfizer-animal-health-unit-ipo-soars.html 2013-02-01T21:30:00Z http://www.mail.com/business/economy/1861868-dow-ends-14000-1st-time-oct-2007.html NEW YORK (AP) — The Dow closed above 14,000 on Friday for the first time in more than five years. It was just a number on a board, but it was enough to raise the hopes of some investors and cause others concern about an overheated market. And it brought reminders of a different era, back before the financial crisis rocked the world economy. ... Fri, 01 Feb 2013 20:54:00 GMT http://www.mail.com/business/economy/1861868-dow-ends-14000-1st-time-oct-2007.html 2013-02-01T20:54:00Z http://www.mail.com/scitech/health/1860326-pfizer-disputes-suit-claiming-zoloft-work.html TRENTON, N.J. (AP) — The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill and that patients who took it should be reimbursed for their costs. Zoloft's maker, Pfizer Inc., the world's biggest drugmaker by revenue, disputes the claim, telling The Associated Press Thursday that clinica... Thu, 31 Jan 2013 21:11:00 GMT http://www.mail.com/scitech/health/1860326-pfizer-disputes-suit-claiming-zoloft-work.html 2013-01-31T21:11:00Z http://www.mail.com/scitech/news/1855678-bp-spill-saga-civil-trial-worth-billions.html NEW ORLEANS (AP) — Now that a $4 billion plea deal has resolved BP's criminal liability for the massive Gulf of Mexico oil spill nearly three years ago, the company will turn its focus to a trial that could potentially cost it billions of dollars more in civil penalties. At the conclusion of a hearing Tuesday that included emotional testimony and a BP exe... Wed, 30 Jan 2013 07:20:00 GMT http://www.mail.com/scitech/news/1855678-bp-spill-saga-civil-trial-worth-billions.html 2013-01-30T07:20:00Z http://www.mail.com/business/economy/1853052-asia-stocks-up-strong-us-earnings.html BANGKOK (AP) — Asian stock markets rose Wednesday after strong U.S. corporate earnings led investors to ignore sagging consumer confidence. Japan's Nikkei rose 1.1 percent to 10,990.77 as the yen continued to weaken against the U.S. dollar. Hong Kong's Hang Seng rose 1 percent to 23,884.24. South Korea's Kospi rose 0.2 percent to 1,959.91 after the govern... Wed, 30 Jan 2013 02:06:00 GMT http://www.mail.com/business/economy/1853052-asia-stocks-up-strong-us-earnings.html 2013-01-30T02:06:00Z http://www.mail.com/scitech/health/1853298-pfizer-q4-net-jumps-sale-nutrition-business.html Drugmaker Pfizer Inc.'s fourth-quarter results easily beat Wall Street expectations, driving up its stock, as profit more than quadrupled, due to tighter spending and a $4.8 billion gain from selling its nutrition business. Those boosts offset competition from generic drugs hurting sales of Lipitor and other medicines. The world's biggest drugmaker said T... Tue, 29 Jan 2013 22:04:00 GMT http://www.mail.com/scitech/health/1853298-pfizer-q4-net-jumps-sale-nutrition-business.html 2013-01-29T22:04:00Z http://www.mail.com/business/economy/1853656-stocks-advance-pushing-dow-toward-14000.html NEW YORK (AP) — Pfizer helped keep the stock market rally alive Tuesday. The drugmaker's stock gained after posting strong earnings, pushing the Dow closer to 14,000. The Dow Jones industrial average rose 73 points to close at 13,954.42 points, ending higher for the seventh day in eight. The Standard and Poor's 500 also rose, adding eight points to 1,507.... Tue, 29 Jan 2013 20:49:00 GMT http://www.mail.com/business/economy/1853656-stocks-advance-pushing-dow-toward-14000.html 2013-01-29T20:49:00Z http://www.mail.com/scitech/news/1854214-judge-oks-4b-bp-oil-spill-criminal-settlement.html NEW ORLEANS (AP) — BP PLC closed the book on the Justice Department's criminal probe of its role in the Deepwater Horizon disaster and Gulf oil spill Tuesday, when a federal judge agreed to let the London-based oil giant plead guilty to manslaughter charges for the deaths of 11 rig workers and pay a record $4 billion in penalties. What the plea deal appro... Tue, 29 Jan 2013 20:26:00 GMT http://www.mail.com/scitech/news/1854214-judge-oks-4b-bp-oil-spill-criminal-settlement.html 2013-01-29T20:26:00Z http://www.mail.com/news/politics/1847012-health-care-early-leaders-sp-500.html NEW YORK (AP) — Health care stocks have started off the year on a tear. The industry group that includes health care providers, drugmakers and biotechnology companies has advanced 7.3 percent this year, making it the second-best in the Standard and Poor's 500 index, trailing only energy companies. Even drugmakers, traditionally considered a safe-haven pla... Sun, 27 Jan 2013 17:48:00 GMT http://www.mail.com/news/politics/1847012-health-care-early-leaders-sp-500.html 2013-01-27T17:48:00Z http://www.mail.com/business/economy/1841404-amgen-4q-profit-drops-16-pct-higher-spending.html Drugmaker Amgen Inc. on Wednesday posted a 16 percent drop in fourth-quarter profit, as higher costs for production, marketing, research and other items offset higher sales for many of its biologic medicines. The results fell a bit short of Wall Street expectations. The world's biggest biotech company, based in Thousand Oaks, Calif., said net income was $... Thu, 24 Jan 2013 01:12:00 GMT http://www.mail.com/business/economy/1841404-amgen-4q-profit-drops-16-pct-higher-spending.html 2013-01-24T01:12:00Z http://www.mail.com/scitech/news/1825498-rig-victims-relatives-weigh-bp-plea-deal.html NEW ORLEANS (AP) — Shelley Anderson, whose husband was one of 11 workers killed in the Deepwater Horizon rig explosion, made a New Year's resolution to try to avoid crying in front of their children. "Like most New Year's resolutions, I didn't do too well. Jason not being with us is hard enough for them to understand. My sorrow only makes that worse," And... Wed, 16 Jan 2013 20:16:00 GMT http://www.mail.com/scitech/news/1825498-rig-victims-relatives-weigh-bp-plea-deal.html 2013-01-16T20:16:00Z http://www.mail.com/scitech/health/1812880-embattled-cancer-agencys-donor-list-revealed.html AUSTIN, Texas (AP) — Major pharmaceutical firms and individuals linked to companies that have benefited from a $3 billion cancer-fighting Texas agency under criminal investigation are among the financial contributors to a nonprofit formed to support the embattled state institute, according to a list of donors released Thursday. Lawmakers and reporters had... Fri, 11 Jan 2013 02:28:00 GMT http://www.mail.com/scitech/health/1812880-embattled-cancer-agencys-donor-list-revealed.html 2013-01-11T02:28:00Z http://www.mail.com/business/economy/1812008-drug-companies-forge-partnerships-with-top-schools.html ST. LOUIS (AP) — In their quest for the next big drug discovery, pharmaceutical companies are increasingly teaming up with some of the nation's top universities, recruiting campus scientists as partners and offering schools multimillion-dollar deals to work on experimental drugs in development. Big Pharma has long sought to profit from academia's innovati... Thu, 10 Jan 2013 20:48:00 GMT http://www.mail.com/business/economy/1812008-drug-companies-forge-partnerships-with-top-schools.html 2013-01-10T20:48:00Z http://www.mail.com/business/economy/1780906-ap-impact-big-pharma-cashes-hgh-abuse.html A federal crackdown on illicit foreign supplies of human growth hormone has failed to stop rampant misuse, and instead has driven record sales of the drug by some of the world's biggest pharmaceutical companies, an Associated Press investigation shows. The crackdown, which began in 2006, reduced the illegal flow of unregulated supplies from China, India a... Mon, 31 Dec 2012 22:20:00 GMT http://www.mail.com/business/economy/1780906-ap-impact-big-pharma-cashes-hgh-abuse.html 2012-12-31T22:20:00Z http://www.mail.com/scitech/health/1774436-amgen-to-pay-762m-settlement-drug-marketing.html Amgen Inc. has agreed to pay $762 million to resolve federal litigation accusing the drugmaker of marketing the anemia treatment Aranesp for unapproved uses. The Thousand Oaks, Calif., company pleaded guilty Tuesday to illegally introducing a misbranded drug into interstate commerce and will pay a $136 million fine and a $14 million forfeiture, according ... Tue, 18 Dec 2012 21:47:00 GMT http://www.mail.com/scitech/health/1774436-amgen-to-pay-762m-settlement-drug-marketing.html 2012-12-18T21:47:00Z http://www.mail.com/scitech/health/1760836-lilly-plans-study-alzheimers-drug.html INDIANAPOLIS (AP) — Eli Lilly's experimental Alzheimer's drug has flashed potential to help with mild cases of the disease, but patients and doctors will have to wait a few more years to learn whether regulators will allow the drugmaker to sell it. Lilly said Wednesday that it will launch another late-stage study of the drug, solanezumab, no later than ne... Wed, 12 Dec 2012 20:42:00 GMT http://www.mail.com/scitech/health/1760836-lilly-plans-study-alzheimers-drug.html 2012-12-12T20:42:00Z